Qiu X, Huang M, Ping S
Front Immunol. 2024; 15:1337528.
PMID: 38375484
PMC: 10875133.
DOI: 10.3389/fimmu.2024.1337528.
Prajjwal P, Kalluru P, Marsool M, Inban P, Gadam S, Al-Ezzi S
Ann Med Surg (Lond). 2023; 85(6):2821-2832.
PMID: 37363482
PMC: 10289738.
DOI: 10.1097/MS9.0000000000000929.
McDougall J, McConnell M, Reid A
Mol Pain. 2021; 17:17448069211016141.
PMID: 34006144
PMC: 8138287.
DOI: 10.1177/17448069211016141.
Atabati H, Yazdanpanah E, Mortazavi H, Gharibian Bajestani S, Raoofi A, Esmaeili S
Adv Exp Med Biol. 2021; 1286:87-105.
PMID: 33725347
DOI: 10.1007/978-3-030-55035-6_6.
Sundaram G, Lim C, Brew B, Guillemin G
J Neuroinflammation. 2020; 17(1):176.
PMID: 32505212
PMC: 7276083.
DOI: 10.1186/s12974-020-01844-y.
Calpain mediated expansion of CD4+ cytotoxic T cells in rodent models of Parkinson's disease.
Haque A, Samantaray S, Knaryan V, Capone M, Hossain A, Matzelle D
Exp Neurol. 2020; 330:113315.
PMID: 32302678
PMC: 7282933.
DOI: 10.1016/j.expneurol.2020.113315.
Cytokine/chemokine dysregulation in progressive MS patient is apparent and can be modulated by calpain inhibition.
Polcyn R, Capone M, Matzelle D, Lueking B, Walker A, Kau E
Metab Brain Dis. 2019; 35(2):255-261.
PMID: 31853829
PMC: 9773329.
DOI: 10.1007/s11011-019-00521-1.
Calpain in the cleavage of alpha-synuclein and the pathogenesis of Parkinson's disease.
Shams R, Banik N, Haque A
Prog Mol Biol Transl Sci. 2019; 167:107-124.
PMID: 31601400
PMC: 8434815.
DOI: 10.1016/bs.pmbts.2019.06.007.
Calpain inhibitor MDL28170 improves the transplantation-mediated therapeutic effect of bone marrow-derived mesenchymal stem cells following traumatic brain injury.
Hu J, Chen L, Huang X, Wu K, Ding S, Wang W
Stem Cell Res Ther. 2019; 10(1):96.
PMID: 30876457
PMC: 6420775.
DOI: 10.1186/s13287-019-1210-4.
Combined Treatment with Methylprednisolone and Human Bone Marrow-Derived Mesenchymal Stem Cells Ameliorate Experimental Autoimmune Encephalomyelitis.
Kim M, Ryu C, Kim S, Lim J, Kim W, Jeun S
Tissue Eng Regen Med. 2019; 15(2):183-194.
PMID: 30603546
PMC: 6171692.
DOI: 10.1007/s13770-017-0101-y.
Distinct Cytokine and Chemokine Expression in Plasma and Calpeptin-Treated PBMCs of a Relapsing-Remitting Multiple Sclerosis Patient: A Case Report.
Chandran R, Capone M, Matzelle D, Polcyn R, Kau E, Haque A
Neurochem Res. 2018; 43(12):2224-2231.
PMID: 30291537
PMC: 9723540.
DOI: 10.1007/s11064-018-2655-z.
Dimethyl Fumarate Therapy Significantly Improves the Responsiveness of T Cells in Multiple Sclerosis Patients for Immunoregulation by Regulatory T Cells.
Schloder J, Berges C, Luessi F, Jonuleit H
Int J Mol Sci. 2017; 18(2).
PMID: 28134847
PMC: 5343807.
DOI: 10.3390/ijms18020271.
Neuron-microglia interaction induced bi-directional cytotoxicity associated with calpain activation.
Podbielska M, Das A, Smith A, Chauhan A, Ray S, Inoue J
J Neurochem. 2016; 139(3):440-455.
PMID: 27529445
PMC: 5374727.
DOI: 10.1111/jnc.13774.
Immune-Inflammatory and Oxidative and Nitrosative Stress Biomarkers of Depression Symptoms in Subjects with Multiple Sclerosis: Increased Peripheral Inflammation but Less Acute Neuroinflammation.
Kallaur A, Lopes J, Oliveira S, Simao A, Reiche E, Regina Delicato de Almeida E
Mol Neurobiol. 2015; 53(8):5191-202.
PMID: 26399644
DOI: 10.1007/s12035-015-9443-4.
CCL27: Novel Cytokine with Potential Role in Pathogenesis of Multiple Sclerosis.
Khaiboullina S, Gumerova A, Khafizova I, Martynova E, Lombardi V, Bellusci S
Biomed Res Int. 2015; 2015:189638.
PMID: 26295034
PMC: 4532821.
DOI: 10.1155/2015/189638.
The immunomodulator AS101 suppresses production of inflammatory cytokines and ameliorates the pathogenesis of experimental autoimmune encephalomyelitis.
Xie L, Chen J, McMickle A, Awar N, Nady S, Sredni B
J Neuroimmunol. 2014; 273(1-2):31-41.
PMID: 24975323
PMC: 4113726.
DOI: 10.1016/j.jneuroim.2014.05.015.
Myelin recovery in multiple sclerosis: the challenge of remyelination.
Podbielska M, Banik N, Kurowska E, Hogan E
Brain Sci. 2014; 3(3):1282-324.
PMID: 24961530
PMC: 4061877.
DOI: 10.3390/brainsci3031282.
Chemokines and chemokine receptors in multiple sclerosis.
Cheng W, Chen G
Mediators Inflamm. 2014; 2014:659206.
PMID: 24639600
PMC: 3930130.
DOI: 10.1155/2014/659206.
Effects of a novel orally administered calpain inhibitor SNJ-1945 on immunomodulation and neurodegeneration in a murine model of multiple sclerosis.
Trager N, Smith A, Wallace Iv G, Azuma M, Inoue J, Beeson C
J Neurochem. 2014; 130(2):268-79.
PMID: 24447070
PMC: 4107076.
DOI: 10.1111/jnc.12659.
Discovery of novel disease-specific and membrane-associated candidate markers in a mouse model of multiple sclerosis.
Dagley L, Croft N, Isserlin R, Olsen J, Fong V, Emili A
Mol Cell Proteomics. 2013; 13(3):679-700.
PMID: 24361864
PMC: 3945902.
DOI: 10.1074/mcp.M113.033340.